Paul-Ehrlich-Institut

Ad­vanced Ther­a­py Medic­i­nal Prod­ucts (ATMP)

Advanced Therapy Medicinal Products (ATMPs) are medicinal products for the use in humans based on genes, tissues or cells.

Chimeric antigen receptor (CAR) on T-cell (Source: Juan Gaertner/ScienceFotoLibrary/Getty Images)

They provide innovative methods of treating diseases and injuries. In Germany, the Paul-Ehrlich-Institut (PEI) is the competent authority for this group of medicines.

ATMPs include gene therapeutics, somatic cell therapeutics, and tissue engineered products.

Updated: 21.11.2019